Skip to main content

Table 1 Comparison of thyroid function between patients of breast benign lesions and cancer on initial diagnosis (mean ± SD)

From: Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine

Thyroid functions

Breast benign lesions patients (n=316)

Breast cancer patients (n=224)

pvalue

T3 (ng/ml)

1.22±0.23*

1.16±0.25

0.002

T4 (μg/dl)

7.12±1.22*

7.34±1.36

0.050

FT3 (pg/ml)

2.92±0.43

2.87±0.38

0.149

FT4 (ng/dl)

0.89±0.13

0.89±0.18

0.650

TSH (μIU/ml)

3.16±4.92

3.92±8.40

0.187

Clinicopathological features of breast cancer

Number

Tumor size

T0 (impalpable)

11

 

T1 (≤2 cm)

84

 

T2 (>2 cm, ≤5 cm)

105

 

T3 (>5 cm)

19

 

Unknown

5

Tumor grade

I

11

 

II

188

 

III

19

 

Unknown

6

Clinical stage

0

9

 

I

63

 

II

132

 

III

11

 

IV

4

 

Unknown

5